论文部分内容阅读
Ponatinib is a multi-target protein tyrosine kinase inhibitor,and its effects on HCC have not been previously explored.In the present study,we investigated its effects on HCC cell growth and the underlying mechanisms.Among a panel of tyrosine kinase inhibitors,ponatinib most effectively decreased the proliferation of three HCC cell lines,SK-HEP-1,SNU-423 and Bel-7402.